Goldman Sachs issues report: Curing diseases is a bad business-model.

[peggysue2]

45. My husband has Type 2 and

it's enormously expensive. He takes pills and shoots up several times a day. Without insurance, we'd be choosing between food and meds. My father-in-law battled stage 4 colon cancer, a huge outlay of costs. When he would go for his chemo, the ward was chock full of patients receiving similar, astronomically expensive treatments.

The bottom line vs the health and lives of patients in this case is grotesque. The idea that it's better for people to suffer than pinch off the money flow speaks to the worst type of capitalism, a truly parasitic relationship sucking the lifeblood of society. But then, this business model has been affecting pharmaceuticals for years where R&D departments have been replaced with MBA's and bean counters.

We all remember the frenzy over 'death panels' in the Obamacare fight. What Goldman has revealed is the death-panel mindset in the financial industries: sick people are just not a good investment if or when they're cured; prolonging the death cycle is good for the bottom line.

I'm surprised this report was released to the public. That being said, these are the sort of conversations/revelations we'll need to prompt change for the future.